Ethnic/Racial Variations in Blood Pressure Awareness, Treatment, and Control

Authors

  • Thomas Giles MD,

    1. From Tulane University School of Medicine, New Orleans, LA;1 the University of Florida College of Medicine, Gainesville, FL;2Rutgers University College of Pharmacy, Piscataway, NJ;3 and Novartis Pharmaceuticals Corporation, East Hanover, NJ4
    Search for more papers by this author
  • 1 Juan M. Aranda Jr MD,

    1. From Tulane University School of Medicine, New Orleans, LA;1 the University of Florida College of Medicine, Gainesville, FL;2Rutgers University College of Pharmacy, Piscataway, NJ;3 and Novartis Pharmaceuticals Corporation, East Hanover, NJ4
    Search for more papers by this author
  • 2 Dong-Churl Suh MBA, PhD,

    1. From Tulane University School of Medicine, New Orleans, LA;1 the University of Florida College of Medicine, Gainesville, FL;2Rutgers University College of Pharmacy, Piscataway, NJ;3 and Novartis Pharmaceuticals Corporation, East Hanover, NJ4
    Search for more papers by this author
  • 3 In-Sun Choi PhD,

    1. From Tulane University School of Medicine, New Orleans, LA;1 the University of Florida College of Medicine, Gainesville, FL;2Rutgers University College of Pharmacy, Piscataway, NJ;3 and Novartis Pharmaceuticals Corporation, East Hanover, NJ4
    Search for more papers by this author
  • 3 Ronald Preblick PharmD, MPH,

    1. From Tulane University School of Medicine, New Orleans, LA;1 the University of Florida College of Medicine, Gainesville, FL;2Rutgers University College of Pharmacy, Piscataway, NJ;3 and Novartis Pharmaceuticals Corporation, East Hanover, NJ4
    Search for more papers by this author
  • 4 Ricardo Rocha MD,

    1. From Tulane University School of Medicine, New Orleans, LA;1 the University of Florida College of Medicine, Gainesville, FL;2Rutgers University College of Pharmacy, Piscataway, NJ;3 and Novartis Pharmaceuticals Corporation, East Hanover, NJ4
    Search for more papers by this author
  • and 4 Feride Frech-Tamas RPh, MPH 4

    1. From Tulane University School of Medicine, New Orleans, LA;1 the University of Florida College of Medicine, Gainesville, FL;2Rutgers University College of Pharmacy, Piscataway, NJ;3 and Novartis Pharmaceuticals Corporation, East Hanover, NJ4
    Search for more papers by this author

Thomas Giles, MD, 109 Holly Drive, Metairie, LA 70005
E-mail: tgiles4@cox.net

Abstract

Understanding the impact of patient factors on blood pressure (BP) management is an important step to developing interventions to improve cardiovascular health. The National Health and Nutrition Examination Survey (NHANES) 1999–2002 was used to identify predictors of hypertension awareness, treatment, and control. An estimated 63.3 million (31.0%) US adults currently have BP exceeding 140/90 mm Hg, and prevalence is higher for blacks than for other racial/ethnic subgroups. Among antihypertensive medication-treated patients, 51.3% are controlled. Treated blacks and Mexican Americans have the lowest rates of BP control. Mexican Americans are 0.62 times as likely to be aware and 0.61 times as likely to be treated as white persons with hypertension. Compared with whites, treated Mexican Americans are 0.71 times as likely and treated blacks 0.59 times as likely to achieve BP control. Hypertension treatment and BP control in the United States remain suboptimal, and significant racial/ethnic disparities persist. Effective interventions targeting Mexican Americans and blacks as well as whites are essential to improving hypertension management.

Ancillary